Literature DB >> 33163514

Is there a safe threshold for alcohol consumption in nonalcoholic fatty liver disease?

Mimi Kim1, Dae Won Jun2.   

Abstract

Entities:  

Year:  2020        PMID： 33163514      PMCID： PMC7603935          DOI： 10.21037/hbsn.2019.11.36

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  11 in total

1.  Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals.

Authors:  Silvia Sookoian; Gustavo O Castaño; Carlos J Pirola
Journal:  Gut       Date:  2013-09-11       Impact factor: 23.059

2.  Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults.

Authors:  Bo Xi; Sreenivas P Veeranki; Min Zhao; Chuanwei Ma; Yinkun Yan; Jie Mi
Journal:  J Am Coll Cardiol       Date:  2017-08-22       Impact factor: 24.094

3.  Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takao Kojima; Yasuhiro Ohshima; Akihiro Ohbora; Takahiro Kato; Naoto Nakamura; Michiaki Fukui
Journal:  J Gastroenterol Hepatol       Date:  2015-03       Impact factor: 4.029

4.  Roles of alcohol consumption in fatty liver: a longitudinal study.

Authors:  Akio Moriya; Yoshiaki Iwasaki; Souhei Ohguchi; Eizo Kayashima; Tadahiko Mitsumune; Hideaki Taniguchi; Masaharu Ando; Kazuhide Yamamoto
Journal:  J Hepatol       Date:  2014-11-27       Impact factor: 25.083

5.  Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Winston Dunn; Arun J Sanyal; Elizabeth M Brunt; Aynur Unalp-Arida; Michael Donohue; Arthur J McCullough; Jeffrey B Schwimmer
Journal:  J Hepatol       Date:  2012-04-17       Impact factor: 25.083

6.  Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.

Authors:  Veeral Ajmera; Patricia Belt; Laura A Wilson; Ryan M Gill; Rohit Loomba; David E Kleiner; Brent A Neuschwander-Tetri; Norah Terrault
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-14       Impact factor: 11.382

7.  Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.

Authors:  Yoosoo Chang; Yong Kyun Cho; Yejin Kim; Eunju Sung; Jiin Ahn; Hyun-Suk Jung; Kyung Eun Yun; Hocheol Shin; Seungho Ryu
Journal:  Hepatology       Date:  2018-12-26       Impact factor: 17.425

8.  Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.

Authors:  Tim Mitchell; Gary P Jeffrey; Bastiaan de Boer; Gerry MacQuillan; George Garas; Helena Ching; Jeffrey Hamdorf; Leon A Adams
Journal:  Am J Gastroenterol       Date:  2018-06-14       Impact factor: 10.864

9.  Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.

Authors:  Angela M Wood; Stephen Kaptoge; Adam S Butterworth; Peter Willeit; Samantha Warnakula; Thomas Bolton; Ellie Paige; Dirk S Paul; Michael Sweeting; Stephen Burgess; Steven Bell; William Astle; David Stevens; Albert Koulman; Randi M Selmer; W M Monique Verschuren; Shinichi Sato; Inger Njølstad; Mark Woodward; Veikko Salomaa; Børge G Nordestgaard; Bu B Yeap; Astrid Fletcher; Olle Melander; Lewis H Kuller; Beverley Balkau; Michael Marmot; Wolfgang Koenig; Edoardo Casiglia; Cyrus Cooper; Volker Arndt; Oscar H Franco; Patrik Wennberg; John Gallacher; Agustín Gómez de la Cámara; Henry Völzke; Christina C Dahm; Caroline E Dale; Manuela M Bergmann; Carlos J Crespo; Yvonne T van der Schouw; Rudolf Kaaks; Leon A Simons; Pagona Lagiou; Josje D Schoufour; Jolanda M A Boer; Timothy J Key; Beatriz Rodriguez; Conchi Moreno-Iribas; Karina W Davidson; James O Taylor; Carlotta Sacerdote; Robert B Wallace; J Ramon Quiros; Rosario Tumino; Dan G Blazer; Allan Linneberg; Makoto Daimon; Salvatore Panico; Barbara Howard; Guri Skeie; Timo Strandberg; Elisabete Weiderpass; Paul J Nietert; Bruce M Psaty; Daan Kromhout; Elena Salamanca-Fernandez; Stefan Kiechl; Harlan M Krumholz; Sara Grioni; Domenico Palli; José M Huerta; Jackie Price; Johan Sundström; Larraitz Arriola; Hisatomi Arima; Ruth C Travis; Demosthenes B Panagiotakos; Anna Karakatsani; Antonia Trichopoulou; Tilman Kühn; Diederick E Grobbee; Elizabeth Barrett-Connor; Natasja van Schoor; Heiner Boeing; Kim Overvad; Jussi Kauhanen; Nick Wareham; Claudia Langenberg; Nita Forouhi; Maria Wennberg; Jean-Pierre Després; Mary Cushman; Jackie A Cooper; Carlos J Rodriguez; Masaru Sakurai; Jonathan E Shaw; Matthew Knuiman; Trudy Voortman; Christa Meisinger; Anne Tjønneland; Hermann Brenner; Luigi Palmieri; Jean Dallongeville; Eric J Brunner; Gerd Assmann; Maurizio Trevisan; Richard F Gillum; Ian Ford; Naveed Sattar; Mariana Lazo; Simon G Thompson; Pietro Ferrari; David A Leon; George Davey Smith; Richard Peto; Rod Jackson; Emily Banks; Emanuele Di Angelantonio; John Danesh
Journal:  Lancet       Date:  2018-04-14       Impact factor: 202.731

10.  Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis.

Authors:  Yoosoo Chang; Seungho Ryu; Yejin Kim; Yong Kyun Cho; Eunju Sung; Han-Na Kim; Jiin Ahn; Hyun-Suk Jung; Kyung Eun Yun; Seolhye Kim; Ki-Chul Sung; Chong Il Sohn; Hocheol Shin; Sarah H Wild; Christopher D Byrne
Journal:  Hepatology       Date:  2019-10-10       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.